ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
about
ICG-001 affects DRP1 activity and ER stress correlative with its anti-proliferative effect.ONC201 kills breast cancer cells in vitro by targeting mitochondria.Developing TRAIL/TRAIL death receptor-based cancer therapies.ATF4 regulated by MYC has an important function in anoikis resistance in human osteosarcoma cells.
P2860
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@ast
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@en
type
label
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@ast
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@en
prefLabel
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@ast
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
@en
P2093
Ambikai Gajan
Dhonghyo Kho
Gen Sheng Wu
Kongming Wu
P2860
P304
21626-21638
P356
10.18632/ONCOTARGET.15451
P407
P577
2017-03-01T00:00:00Z